[{"NetIncomeLoss_1_Q2_USD":-27215000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":20000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":831374.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-196212000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":291000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"DueFromRelatedPartiesCurrent_0_Q2_USD":7331000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1069000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":58752494.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":44025372.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5091000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":10262000.0,"DepreciationAndAmortization_1_Q2_USD":600000.0,"DepreciationAndAmortization_2_Q2_USD":1300000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":55800000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":4173000.0,"AssetsCurrent_0_Q2_USD":340381000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6083832.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2541000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":4215000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":11499000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":252300000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":11195136.0,"MarketableSecuritiesCurrent_0_Q2_USD":301469000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":28892000.0,"Assets_0_Q2_USD":453957000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_2_Q2_USD":-1406000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":325351000.0,"CommonStockSharesIssued_0_Q2_shares":59015868.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":5144000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":86000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":6083832.0,"ShareBasedCompensation_2_Q2_USD":3584000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":33956000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":255000.0,"TemporaryEquitySharesIssued_0_Q2_shares":0.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":63280000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1272000.0,"CommonStockValue_0_Q2_USD":6000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-58000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-733000.0,"ProceedsFromStockPlans_2_Q2_USD":113000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":252408000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":1913729.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":1069000.0,"TemporaryEquityLiquidationPreference_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":1801000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":48729000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":32918000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":60375000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-274000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":0.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"RestrictedCash_0_Q2_USD":1084000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-27215000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":217000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":127000.0,"FinanceLeaseLiability_0_Q2_USD":107000.0,"Liabilities_0_Q2_USD":93459000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":564321000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":30337000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":23976000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-48953000.0,"GoodwillTranslationAndPurchaseAccountingAdjustments_2_Q2_USD":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.0001,"AmortizationOfIntangibleAssets_2_Q2_USD":534000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":300000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-941000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":3451000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-26960000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-46517000.0,"OtherAssetsNoncurrent_0_Q2_USD":411000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2240000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":21571000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_Q2_shares":289588.0,"AccountsPayableCurrent_0_Q2_USD":10173000.0,"LiabilitiesCurrent_0_Q2_USD":43737000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":4381000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-48009000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2017000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-27273000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-47467000.0,"Goodwill_0_Q2_USD":14608000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":311000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":6830000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":1069000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":5691470.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":305205000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1069000.0,"RestrictedCashNoncurrent_0_Q2_USD":1084000.0,"NonoperatingIncomeExpense_2_Q2_USD":1599000.0,"NonoperatingIncomeExpense_1_Q2_USD":711000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":25060000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":7605000.0,"NetIncomeLoss_2_Q2_USD":-46734000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":7102000.0,"DividendsCommonStock_2_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":530000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":7085000.0,"OperatingLeasePayments_1_Q2_USD":500000.0,"CommonStockSharesOutstanding_0_Q2_shares":59015868.0,"OperatingLeasePayments_2_Q2_USD":1300000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":32675.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":25060000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":734000.0,"SubleaseIncome_1_Q2_USD":500000.0,"SubleaseIncome_2_Q2_USD":900000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.071,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":61479000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":5679000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":8187000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-204120000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5691470.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2017000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3584000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":453957000.0,"OperatingLeaseCost_1_Q2_USD":700000.0,"OperatingLeaseCost_2_Q2_USD":1100000.0,"PreferredStockValue_0_Q2_USD":null,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":23700000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":7480000.0,"InvestmentIncomeInterest_2_Q2_USD":1639000.0,"OtherNonoperatingExpense_1_Q2_USD":19000.0,"OtherNonoperatingExpense_2_Q2_USD":40000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":5000.0,"OperatingIncomeLoss_1_Q2_USD":-27984000.0,"OperatingIncomeLoss_2_Q2_USD":-49066000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q2_shares":260742.0,"InvestmentIncomeInterest_1_Q2_USD":730000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":10025000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":25528.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3619000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":18000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":870000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":325060000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1077000.0,"StockholdersEquity_0_Q2_USD":360498000.0,"OtherLiabilitiesCurrent_0_Q2_USD":78000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":107000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":13932000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":691000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.46,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.11,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":21188000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":1286000.0,"OperatingExpenses_1_Q2_USD":38009000.0,"OperatingExpenses_2_Q2_USD":70637000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":533000.0,"ProfitLoss_2_Q2_USD":-46734000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":557000.0,"Ticker":"RVMD","CIK":"1628171","name":"REVOLUTION MEDICINES, INC.","OfficialName":"Revolution Medicines Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1775342076.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]